GUSBP11 and hepatocellular carcinoma: In accordance with our data for EOC, high expression levels of GUSBP11 are predicted to bind miR-22-3p to avoid CCN2A mRNA degradation, correlating to poor overall survival in hepatocellular carcinoma patients [81].